Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base.

Petrie MC, Boyle JG, McKay GA.

Diabet Med. 2015 Jan 23. doi: 10.1111/dme.12709. [Epub ahead of print]

PMID:
25645049
2.

Differences in level of confidence in diabetes care between different groups of trainees: the TOPDOC diabetes study.

Smith CJ, George JT, Warriner D, McGrane DJ, Rozario KS, Price HC, Wilmot EG, Kar P, Stratton IM, Jude EB, McKay GA.

BMC Med Educ. 2014 Sep 17;14:191. doi: 10.1186/1472-6920-14-191.

3.

A simple tool to predict admission at the time of triage.

Cameron A, Rodgers K, Ireland A, Jamdar R, McKay GA.

Emerg Med J. 2015 Mar;32(3):174-9. doi: 10.1136/emermed-2013-203200. Epub 2014 Jan 13.

4.

Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee Doctors Engaged in Clinical Training (PROTECT) study.

Ryan C, Ross S, Davey P, Duncan EM, Francis JJ, Fielding S, Johnston M, Ker J, Lee AJ, MacLeod MJ, Maxwell S, McKay GA, McLay JS, Webb DJ, Bond C.

PLoS One. 2014 Jan 3;9(1):e79802. doi: 10.1371/journal.pone.0079802. eCollection 2014.

5.

Spontaneous remission in a case of idiopathic retroperitoneal fibrosis.

Williams G, Sarkar B, Neilly JB, McKay GA.

Scott Med J. 2013 May;58(2):e7-9. doi: 10.1177/0036933012474607.

PMID:
23728768
6.

Diabetes control in older people.

McLaren LA, Quinn TJ, McKay GA.

BMJ. 2013 Apr 24;346:f2625. doi: 10.1136/bmj.f2625. No abstract available. Erratum in: BMJ. 2013;346:f2836.

PMID:
23615598
7.

Learning curves, taking instructions, and patient safety: using a theoretical domains framework in an interview study to investigate prescribing errors among trainee doctors.

Duncan EM, Francis JJ, Johnston M, Davey P, Maxwell S, McKay GA, McLay J, Ross S, Ryan C, Webb DJ, Bond C; PROTECT Study Group.

Implement Sci. 2012 Sep 11;7:86. doi: 10.1186/1748-5908-7-86.

8.

Patient education on the benefit and risks of medications goes beyond metformin.

McKay GA, Boyle JG.

Diabet Med. 2012 Nov;29(11):1471-2. doi: 10.1111/j.1464-5491.2012.03754.x. No abstract available.

PMID:
22817327
9.

Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes Study.

George JT, Warriner D, McGrane DJ, Rozario KS, Price HC, Wilmot EG, Kar P, Stratton IM, Jude EB, McKay GA; TOPDOC Diabetes Study Team.

QJM. 2011 Sep;104(9):761-6. doi: 10.1093/qjmed/hcr046. Epub 2011 Apr 21.

10.

Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing.

Belley A, McKay GA, Arhin FF, Sarmiento I, Beaulieu S, Fadhil I, Parr TR Jr, Moeck G.

Antimicrob Agents Chemother. 2010 Dec;54(12):5369-71. doi: 10.1128/AAC.00760-10. Epub 2010 Sep 27.

11.

Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target.

Boyle JG, Salt IP, McKay GA.

Diabet Med. 2010 Oct;27(10):1097-106. doi: 10.1111/j.1464-5491.2010.03098.x. Review.

PMID:
20854376
12.

Protocol for a national audit on self-reported confidence levels, training requirements and current practice among trainee doctors in the UK: the Trainees Own Perception of Delivery of Care in Diabetes (TOPDOC) Study.

George JT, McGrane DJ, Warriner D, Rozario KS, Price HC, Wilmot EG, Kar P, Jude EB, McKay GA; TOPDOC Study Team.

BMC Med Educ. 2010 Jul 27;10:54. doi: 10.1186/1472-6920-10-54.

13.

Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.

Arhin FF, Belley A, McKay GA, Moeck G.

Curr Protoc Microbiol. 2010 Feb;Chapter 17:Unit17.1. doi: 10.1002/9780471729259.mc1701s16.

PMID:
20131224
14.

Time-kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes.

Arhin FF, McKay GA, Beaulieu S, Sarmiento I, Parr TR Jr, Moeck G.

Int J Antimicrob Agents. 2009 Dec;34(6):550-4. doi: 10.1016/j.ijantimicag.2009.08.012. Epub 2009 Oct 8.

PMID:
19818587
15.

A combined diabetes renal clinic improves risk factor management and progression of renal disease in a district general hospital.

Patel M, Shilliday IR, McKay GA.

J Eval Clin Pract. 2009 Oct;15(5):832-5. doi: 10.1111/j.1365-2753.2008.01097.x.

PMID:
19811597
16.

Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus.

Arhin FF, McKay GA, Beaulieu S, Sarmiento I, Parr TR Jr, Moeck G.

Diagn Microbiol Infect Dis. 2009 Oct;65(2):207-10. doi: 10.1016/j.diagmicrobio.2009.05.022.

PMID:
19748436
17.

Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T Jr, Moeck G.

J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15.

18.

Impact of human serum albumin on oritavancin in vitro activity against enterococci.

McKay GA, Beaulieu S, Sarmiento I, Arhin FF, Parr TR Jr, Moeck G.

Antimicrob Agents Chemother. 2009 Jun;53(6):2687-9. doi: 10.1128/AAC.00197-09. Epub 2009 Apr 6.

19.

Therapeutic strategies in the treatment of diabetic nephropathy - a translational medicine approach.

Shah IM, Mackay SP, McKay GA.

Curr Med Chem. 2009;16(8):997-1016. Review.

PMID:
19275608
20.

Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.

Belley A, Neesham-Grenon E, Arhin FF, McKay GA, Parr TR Jr, Moeck G.

Antimicrob Agents Chemother. 2008 Oct;52(10):3820-2. doi: 10.1128/AAC.00361-08. Epub 2008 Jul 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk